SCPHARMACEUTICALS INC. Accrued Liabilities, Current
SCPHARMACEUTICALS INC. had Accrued Liabilities, Current of $16.08 million as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2025-08-07
- 2025-06-30: Accrued Liabilities, Current $16.08M.
- 2025-03-31: Accrued Liabilities, Current $10.86M.
- 2024-12-31: Accrued Liabilities, Current $10.70M.
- 2024-09-30: Accrued Liabilities, Current $9.87M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2025-06-30 | $16.08M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $10.86M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $10.70M 10-Q · filed 2025-08-07 |
| 2024-09-30 | $9.87M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $7.40M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $9.21M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $8.90M 10-K · filed 2025-03-19 |
| 2023-09-30 | $7.11M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $5.12M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $5.56M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $5.29M 10-K · filed 2024-03-13 |
| 2022-09-30 | $5.18M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $4.13M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $3.48M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $4.00M 10-K · filed 2023-03-22 |
| 2021-09-30 | $3.48M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $3.58M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $3.58M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $4.79M 10-K · filed 2022-03-22 |
| 2020-09-30 | $5.91M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $4.72M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $3.59M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $3.69M 10-K · filed 2021-03-23 |
| 2019-09-30 | $7.17M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $7.11M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $5.47M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $2.92M 10-K · filed 2020-03-24 |
| 2018-09-30 | $2.21M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $2.56M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.74M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $3.06M 10-K · filed 2019-03-21 |